Search research articles
Contact Us
Filters
Showing results (31-40 of 189) with videos related to
Page
of 19
Sort By:
The Prostate
|
March 7, 2022
Immune mechanisms behind prostate cancer in men of African ancestry: A review
Daniel Sentana-Lledo, Oliver Sartor, Steven P Balk, et al.
The Journal of Biological Chemistry
|
July 23, 2009
Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase 1
Shaoyong Chen, Cristina T Kesler, Bryce M Paschal, et al.
Cancer Research
|
August 4, 2006
Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins
Youyuan Xu, Shao-Yong Chen, Kenneth N Ross, et al.
Cancer Research
|
December 4, 2012
Clonal progression of prostate cancers from Gleason grade 3 to grade 4
Adam G Sowalsky, Huihui Ye, Glenn J Bubley, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 23, 2014
Pillars article: analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCR α chain. J. Exp. Med. 1993. 178: 1-16
Steven Porcelli, Courtland E Yockey, Michael B Brenner, et al.
The Prostate
|
June 9, 2016
Mutation Profiling Indicates High Grade Prostatic Intraepithelial Neoplasia as Distant Precursors of Adjacent Invasive Prostatic Adenocarcinoma
Sean J Gerrin, Adam G Sowalsky, Steven P Balk, et al.
The Prostate
|
November 13, 2004
Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation
Xinyu S Fu, Eunis Choi, Glenn J Bubley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 18, 2006
Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1
Shaoyong Chen, Youyuan Xu, Xin Yuan, et al.
Molecular Cancer Therapeutics
|
October 15, 2008
Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor
Myles C Hodgson, Howard C Shen, Anthony N Hollenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
Natural killer T cell-based cancer immunotherapy
Hans J J van der Vliet, Steven P Balk, Mark A Exley
Page
of 19
Search research articles
Search
Showing results (31-40 of 189) with videos related to
Sort By:
Page
of 19
The Prostate
|
March 7, 2022
Immune mechanisms behind prostate cancer in men of African ancestry: A review
Daniel Sentana-Lledo, Oliver Sartor, Steven P Balk, et al.
The Journal of Biological Chemistry
|
July 23, 2009
Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase 1
Shaoyong Chen, Cristina T Kesler, Bryce M Paschal, et al.
Cancer Research
|
August 4, 2006
Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins
Youyuan Xu, Shao-Yong Chen, Kenneth N Ross, et al.
Cancer Research
|
December 4, 2012
Clonal progression of prostate cancers from Gleason grade 3 to grade 4
Adam G Sowalsky, Huihui Ye, Glenn J Bubley, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 23, 2014
Pillars article: analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- α/β T cells demonstrates preferential use of several Vβ genes and an invariant TCR α chain. J. Exp. Med. 1993. 178: 1-16
Steven Porcelli, Courtland E Yockey, Michael B Brenner, et al.
The Prostate
|
June 9, 2016
Mutation Profiling Indicates High Grade Prostatic Intraepithelial Neoplasia as Distant Precursors of Adjacent Invasive Prostatic Adenocarcinoma
Sean J Gerrin, Adam G Sowalsky, Steven P Balk, et al.
The Prostate
|
November 13, 2004
Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation
Xinyu S Fu, Eunis Choi, Glenn J Bubley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 18, 2006
Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1
Shaoyong Chen, Youyuan Xu, Xin Yuan, et al.
Molecular Cancer Therapeutics
|
October 15, 2008
Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor
Myles C Hodgson, Howard C Shen, Anthony N Hollenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
Natural killer T cell-based cancer immunotherapy
Hans J J van der Vliet, Steven P Balk, Mark A Exley
Page
of 19